celgosivir has been researched along with Disease Models, Animal in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, KW; Dow, G; Low, JG; Ooi, EE; Vasudevan, SG; Watanabe, S | 1 |
| Connolly, JE; Low, J; Ooi, EE; Paradkar, PN; Rathore, AP; Sung, C; Tan, KH; Vasudevan, SG; Watanabe, S | 1 |
| Connolly, J; Khoo, YM; Lee, HS; Low, J; Lu, F; Ooi, EE; Rathore, AP; Sung, C; Vasudevan, SG; Watanabe, S | 1 |
| Ahmed, P; Patel, D; Taylor, D; Tyms, AS; Whitby, K | 1 |
| Flamand, M; Liu, W; Schul, W; Vasudevan, SG; Xu, HY | 1 |
5 other study(ies) available for celgosivir and Disease Models, Animal
| Article | Year |
|---|---|
Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: The search for a window for potential therapeutic efficacy.
Topics: alpha-Glucosidases; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cricetinae; Cytokines; Dengue; Dengue Virus; Disease Models, Animal; Enzyme Inhibitors; Humans; In Vitro Techniques; Indolizines; Mice; Real-Time Polymerase Chain Reaction; Serogroup; Vero Cells; Viral Load; Viremia | 2016 |
Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model.
Topics: Animals; Antiviral Agents; Cell Line; Cricetinae; Dengue; Dengue Virus; Disease Models, Animal; Humans; Indolizines; Mice; Mice, 129 Strain; Microbial Sensitivity Tests; Protein Binding; Protein Folding; Signal Transduction; Unfolded Protein Response; Viral Nonstructural Proteins | 2011 |
Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial.
Topics: Animals; Antiviral Agents; Dengue; Dengue Virus; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy; Indolizines; Mice; Survival Analysis | 2012 |
Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C.
Topics: alpha-Glucosidases; Animals; Antiviral Agents; Bovine Virus Diarrhea-Mucosal Disease; Cattle; Cell Line; Cytopathogenic Effect, Viral; Diarrhea Viruses, Bovine Viral; Disease Models, Animal; Drug Synergism; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Hepacivirus; Hepatitis C; Humans; Indolizines; Inhibitory Concentration 50; Interferon-alpha; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Viral Envelope Proteins; Viral Plaque Assay | 2004 |
A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs.
Topics: 1-Deoxynojirimycin; Animals; Antiviral Agents; Dengue; Disease Models, Animal; Dose-Response Relationship, Drug; Indolizines; Mice; Ribavirin; Time Factors; Tubercidin; Viremia; Virus Replication | 2007 |